CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication
April 2020: Special Communication – Test Discontinuations & Build Changes
Special Communication
Changes to Test Build
N-Methylhistamine, Urine (MHISTA)
Effective April 30, 2020.
Aminolevulinic Acid Dehydratase (ALAD), Whole Blood (ALADWB)
Effective May 7, 2020.
Autoimmune Dysautonomia Evaluation, Serum (AIDYSA)
Effective May 14, 2020.
Paraneoplastic Autoantibody Evaluation, CSF (PARCSF)
Effective May 14, 2020.
Paraneoplastic Autoantibody Evaluation, Serum (PARNEO)
Effective May 14, 2020.
Phosphatidylethanol (PEth) (PETH)
Effective May 18, 2020.
Any additional information regarding this testing will be included in a future Technical Update.
If you have any questions about these changes, please contact Client Services for assistance.
